Tumor formation suppressed in γδT knock-out mice

Cancer Letters

Volumn 153, Issue 1-2, 2000, Pages 63-66

  Zhang, Ben Ning ^a   Watanabe, Satoru ^a   Kohyama, Masako ^a   Saijo, Kaoru ^a   Kusakabe, Moriaki ^a   Ohno, Tadao ^a  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

T KO mice; T KO mice; Hepatoma; Tumor suppression

Indexed keywords

CHEMOKINE; CYTOKINE; GROWTH FACTOR; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HEPATOMA CELL; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR VOLUME;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0034729506     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00343-8     Document Type: Article

References (17)

1. Tanaka Y., Morita C.T., Tanaka Y., Nieves E., Brenner M.B., Bloom B.R. Natural and symthetic non-peptide antigens recognized by human γδT cells. Nature. 375:1995;156-158.
2. Groh V., Steinle A., Bauer S., Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science. 279:1998;1737-1740.
3. Schild H., Mavaddat N., Litzenberger C., Ehrich E.W., Davis M.M., Bluestone J.A., Matis L., Draper R.K., Chien Y.H. The nature of major histocompatibility complex recognition by γδ T cells. Cell. 76:1994;29-37.
4. Havran W.L., Chien Y.H., Allison J.P. Recognition of self antigens by skin-derived T cells with invariant γδ antigen receptors. Science. 252:1991;1430-1432.
5. Boismenu R., Havran W.L. Modulation of epithelial cell growth by intraepithelial γδ T cells. Science. 266:1994;1253-1255.
6. Zuany-Amorin C., Ruffie C., Haile S., Vargaftig B.B., Pereira P., Pretolani M. Requirement for γδ T cells in allergic airway inflammation. Science. 280:1998;1265-1267.
7. Boismenu R., Feng L., Xia Y.Y., Chang J.C.C., Havran W.L. Chemokine expression by intraepithelial γδ T cells. Implications for the recruitment of inflammatory cells to damaged epithelia, J. Immunol. 157:1996;985-992.
8. Ferrick D.A., Schrenzel M.D., Mulvania T., Hsieh B., Ferlin W.G., Lepper H. Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo. Nature. 373:1995;255-257.
9. Williams N. T cells on the mucosal frontline. Science. 280:1998;198-200.
10. Lahn M., Kanehio A., Takeda K., Joetham A., Schwarze J., Kohler G., O'Brien R., Gelfand E.W., Born W. Negative regulation of airway responsiveness that is dependent on γδT cells and independent of αβT cells. Nat. Med. 5:1999;1150-1156.
11. Fisch P., Malkovsky M., Braakman E., Sturm E., Bolhuis R.L., Prieve A., Sosman J.A., Lam V.A., Sondel P.M. γδT cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis. J. Exp. Med. 171:1990;1567-1579.
12. Libero D., Casorati G., Giachino C., Carbonara C., Migone N., Matzinger P., Oanzavecchia A. Selection by two powerful antigens may account for the presence of the major population of human peripheral γδT cells. J. Exp. Med. 173:1991;1311-1322.
13. Suzuki Y., Fujimiya Y., Ohno T., Katakura R., Yoshimoto T. Enhancing effect of tumor necrosis factor (TNF)-α, but not IFN-γ, on the tumor-specific cytotoxicity of γδT cells from glioblastoma patients, Cancer Lett. 140:1999;161-167.
14. - γδT cells from glioblastoma patients. Clin. Cancer Res. 3:1997;633-643.
15. Yamaguchi T., Fujimiya Y., Suzuki Y., Katakura R., Ebina T. A simple method for the propagation of γδT cells from the peripheral blood of glioblastoma patients using solid-phase ant-CD3 antibody and soluble IL-2. J. Immunol. Methods. 205:1997;19-28.
16. Seo N., Tokura Y., Furukawa F., Takigawa M. Down-regulation of tumoricidal NK and NK-T cell activities by MHC Kb molecules expressed on Th2-type γδT and αβT cells coinfiltrating in early B16 melanoma lesions. J. Immunol. 161:1998;4138-4145.
17. Seo N., Tokura Y., Takigawa M., Egawa K. Depletion of IL-10- and TGFβ-producing regulatory γδT cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells. J. Immunol. 163:1999;242-249.